//
Chang Gong
Weige Tan
Kai Chen
Na You
Shan Zhu
Wei Luo
Xinhua Xie
Yunjie Zeng
Nengtai Ouyang
Zhihua Li
Musheng Zeng
Shimei Zhuang
Wan-Yee Lau
Qiang Liu
Fengxi Su
Xueqin Wang
Erwei Song
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
Department of Statistical Science, School of Mathematics and Computational Science & Southern China Research Center of Statistical Science, Sun Yat-sen University, Guangzhou, China
State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Department of Biotherapy, Guangzhou, China
Department of Oncology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China
Prevention and Cure Center of Breast Disease, Key Laboratory of Breast disease, the Third Hospital of Nanchang City, Nanchang, China
Key Laboratory of Gene Engineering of Ministry of Education, Collaborative Innovation Center for Cancer Medicine, School of Life Science, Sun Yat-sen University, Guangzhou, China
Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong, Hong Kong, China
China
N/A
Oncology (ONC)
Breast cancer
Human epidermal growth factor receptor 2
N/A
N/A
N/A
NA
N/A
N/A
Final